MGX logo

Metagenomi (MGX) Company Overview

Profile

Full Name:

Metagenomi, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 6, 2006

Indexes:

Not included

Description:

MGX (Metagenomi) focuses on gene editing technologies to develop innovative therapies for genetic diseases. The company uses advanced tools to modify genes, aiming to improve health outcomes and create new treatment options. Their work combines biotechnology and medicine to address unmet medical needs.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 10, 24 HC Wainwright & Co.
Buy
Nov 21, 24 HC Wainwright & Co.
Buy
Nov 20, 24 Chardan Capital
Buy
Oct 15, 24 HC Wainwright & Co.
Buy
Sep 6, 24 HC Wainwright & Co.
Buy
Sep 5, 24 Chardan Capital
Buy
Aug 21, 24 HC Wainwright & Co.
Buy
Aug 19, 24 Chardan Capital
Buy
Aug 15, 24 BMO Capital
Outperform
Jul 15, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Metagenomi?
  • Does Metagenomi pay dividends?
  • What sector is Metagenomi in?
  • What industry is Metagenomi in?
  • What country is Metagenomi based in?
  • When did Metagenomi go public?
  • Is Metagenomi in the S&P 500?
  • Is Metagenomi in the NASDAQ 100?
  • Is Metagenomi in the Dow Jones?
  • When was Metagenomi's last earnings report?
  • When does Metagenomi report earnings?
  • Should I buy Metagenomi stock now?

What is the ticker symbol for Metagenomi?

The ticker symbol for Metagenomi is NASDAQ:MGX

Does Metagenomi pay dividends?

No, Metagenomi does not pay dividends

What sector is Metagenomi in?

Metagenomi is in the Healthcare sector

What industry is Metagenomi in?

Metagenomi is in the Biotechnology industry

What country is Metagenomi based in?

Metagenomi is headquartered in United States

When did Metagenomi go public?

Metagenomi's initial public offering (IPO) was on April 6, 2006

Is Metagenomi in the S&P 500?

No, Metagenomi is not included in the S&P 500 index

Is Metagenomi in the NASDAQ 100?

No, Metagenomi is not included in the NASDAQ 100 index

Is Metagenomi in the Dow Jones?

No, Metagenomi is not included in the Dow Jones index

When was Metagenomi's last earnings report?

Metagenomi's most recent earnings report was on Nov 13, 2024

When does Metagenomi report earnings?

The next expected earnings date for Metagenomi is Feb 28, 2025

Should I buy Metagenomi stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions